These findings suggest that KLK6 is an important protease implicated in different CNS disorders in which its expression is altered in a disease-dependent manner, indicating that KLK6 may be an important therapeutic candidate to be used to ameliorate some of the effects produced by multiple sclerosis or Parkinson’s disease. This evidence concerns the gene KLK6 and central nervous system disorder.